Suchergebnisse - "Preotescu, Liliana-Lucia"

PubPharm (4)

1

Therapeutic developments for SARS-CoV-2 infection-Molecular mechanisms of action of antivirals and strategies for mitigating resistance in emerging variants in clinical practice

enthalten in: Frontiers in microbiology | 2023

von Săndulescu, O. | Apostolescu, C. | Preoțescu, L. | +2

2

A Randomized Clinical Trial of Regdanvimab in High-Risk Patients With Mild-to-Moderate Coronavirus Disease 2019

enthalten in: Open forum infectious diseases | 2022

von Kim, J. | Săndulescu, O. | Preotescu, L. | +21

ErratumIn: Open Forum Infect Dis. 2023 Apr 19;10(4):ofad196. - PMID 37089779

3

Efficacy and Safety of Regdanvimab (CT-P59) : A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial in Outpatients With Mild-to-Moderate Coronavirus Disease 2019

enthalten in: Open forum infectious diseases | 2022

von Streinu-Cercel, A. | Săndulescu, O. | Preotescu, L. | +14

4

Efficacy and safety of CT-P59 plus standard of care: a phase 2/3 randomized, double-blind, placebo-controlled trial in outpatients with mild-to-moderate SARS-CoV-2 infection

enthalten in: ResearchSquare.com | 2021

von Eom, J. | Ison, M. | Streinu-Cercel, A. | +15

1
[1]